Molecular Diagnostics & Genetics

6.25 CME Credits

5 February 2020
Dubai World Trade Centre

09:00

Opening remarks

Dr Fadi W. Abdul-Karim, Prof Emeritus, Cleveland Clinic Lerner School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA

Session 1

Moderator: Dr Val V. Zvereff, Head of Molecular Diagnostic Department, National Reference Laboratory, Abu Dhabi University, Abu Dhabi,

09:15

Keynote presentation: The growing importance of molecular “omic” technologies in modern pathology

Prof Jo Martin, President, Royal College of Pathologists; Clinical Director of Diagnostics and Therapeutics Directorate, Barts & The London NHS Trust, London, UK

09:45

Advancement in genetics leading to Personalised Medicine for Arab genotypes

HE Dr Maryam Matar, Founder & Chairperson, UAE Genetic Diseases Association, Dubai, UAE

10:15 

Coffee break

Session 2

Moderator: Prof Rami Mahfouz, Head - Division Clinical Pathology; Director - Molecular Diagnostics Laboratory; Director - Residency Training Program & Vice Chair - Biomedical IRB; Interim Director - Pillar Genomics Institute, Department of Pathology  and Laboratory Medicine, American University of Beirut Medical Centre, Beirut, Lebanon

10:45

Utility of clinical genomics

Dr Ahmad Abou Tayoun, Head of Genomic Diagnostics, Al Jalila Specialty Hospital, Dubai, UAE

11:15

Sequencing of tumors in clinical genomics

Dr Val V. Zvereff, Head of Molecular Diagnostics Department, National Reference Laboratory, Abu Dhabi, UAE 

11:45

Clinical relevance of somatic mutations in neuro-development disorders

Prof Jashim Uddin, Assistant Professor - Human Genetics, Mohammed Bin Rashid University of Medicine & Health Sciences (MBRU), Dubai, UAE

12:15

Lunch break and visit exhibition

Session 3

Moderator: Dr Ahmad Abou Tayoun, Head of Genomic Diagnostics, Al Jalila Specialty Hospital, Dubai, UAE

13:45

The future of liquid biopsy

Prof Rami Mahfouz, Head - Clinical Division Pathology; Director - Molecular Diagnostics Laboratory; Director - Residency Training Program; Vice Chair - Biomedical IRB; Interim Director - Pillar Genomics Institute, American University of Beirut, Beirut, Lebanon

14:45

Genetics and heterogeneity of type 2 diabetes

Prof Leif Groop, Senior Professor, Lund University, Sweden; Research Director, Institute of Molecular Medicine Finland (FIMM) Helsinki, Finland

15:15

Coffee break

Session 4

15:45

Challenges on predictive biomarker testing in precision oncology

Dr Naravat Poungvarin, Lecturer - Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

16:15

The bioinformatics and automated processing of phenomics data in Personalised Diagnostics - a working example of mass spectral pattern recognition

Prof Ricardo Pais, Data Scientist, MAPSciences, Lisbon, Portugal

Session 5

Moderator: Dr Val V. Zvereff, Head of Molecular Diagnostic Department, National Reference Laboratory, Abu Dhabi, UAE

16:45

Panel discussion: Changing clinical pathology, new techniques, new answers new ways of thinking

Participants will discuss new tools, what can be done now, what is needed to address grand challenges in clinical pathology?

Moderator: Dr Val V. Zvereff, Head of Molecular Diagnostics, National Reference Boratory, Abu Dhabi, UAE

Panelists:

  1. Prof Jo Martin, President, Royal College of Pathologists; Clinical Director of Diagnostics and Therapeutics Directorate, Barts & The London NHS Trust, London, UK
  2. Prof Leif Groop, Senior Professor, Lund University, Sweden; Research Director, Institute of Molecular Medicine Finland (FIMM) Helsinki, Finland
  3. Dr Ahmad Abou Tayoun, Head of Genomic Diagnostics, Al Jalila Specialty Hospital, Dubai, UAE
  4. Prof Rami Mahfouz, Head - Division Clinical Pathology; Director - Molecular Diagnostics Laboratory; Director - Residency Training Program; Vice Chair - Biomedical IRB; Intetrim Director - Pillar Genomics Institute, Department of Pathology and Laboratory Medicine, American Univeristy of Beirut, Beirut, Lebanon 

17:45

End of conference